Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Luye Pharma Group Limited Proxy Solicitation & Information Statement 2020

Jan 5, 2020

50431_rns_2020-01-05_2168ab25-da01-4463-aa2b-9559015c9426.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

==> picture [170 x 76] intentionally omitted <==

LUYE PHARMA GROUP LTD.

綠 葉 製 藥 集 團 有 限 公 司

(incorporated in Bermuda with limited liability)

(Stock Code: 02186)

PROXY FORM FOR SPECIAL GENERAL MEETING

I/We, being the registered holder(s) of Luye Pharma Group[1)] Ltd. (the ‘‘Company’’), hereby appoint the proxy[(Note][1)] as specified below or failing him/her, the chairman of the meeting[(Note] to attend and vote for me/us and on my/our behalf at the Special General Meeting of the Company to be held at Taishan Room, 5/F, Island Shangri-La, Supreme Court Road, Central, Hong Kong on Wednesday, 22 January 2020 at 10:00 a.m. and at any adjournment thereof in respect of the resolution as indicated below, or if no such indication is given, as my/our proxy thinks fit.

Registered Holder(s) (Complete in ENGLISH BLOCK CAPITALS. The names of all joint holders should be stated.) Registered Name

Registered Address

Certificate No.[(Note][7)]

Date

Signature[(Note][3)]

Proxy[(Note][1)] (Complete in ENGLISH BLOCK CAPITALS.)

Full Name No. of Shares[(Note][2)]

Full Address

ORDINARY RESOLUTION FOR[(Note][4)] AGAINST[(Note][4)]

  1. (a) the execution and delivery of and the performance of the obligations under the Sale and Purchase Agreement dated 1 December 2019 (the ‘‘Sale and Purchase Agreement’’) in respect of the acquisition of 98.0% equity interest in 山東博安生物技術有限公司 (Shandong Boan Biological Technology Co. Ltd.) (the ‘‘Acquisition’’) entered into between 綠葉投資集團有限公司 (Luye Investment Group Co., Ltd.) and the 山東綠葉製藥有限公司 (Shandong Luye Pharmaceutical Co. Ltd.) (a copy of the Sale and Purchase Agreement has been tabled at the meeting and marked ‘‘A’’ for the purpose of identification) and the transactions contemplated thereunder be and are hereby approved, confirmed and ratified; and

    • (b) any one director of the Company be and is hereby authorised to sign, agree, ratify, perfect, execute or deliver (including under seal where applicable) such documents and to do or authorise doing all such acts and things incidental to the Acquisition and the transactions contemplated under the Sale and Purchase Agreement as he may in his absolute discretion consider necessary, desirable or expedient and in the best interest of the Company in connection with the implementation of, giving effect to or completion of the Acquisition under the Sale and Purchase Agreement and the transactions contemplated thereunder.

Notes:

  1. If any proxy other than the chairman of the meeting is preferred, please insert the full name and address of the proxy desired in the space provided. A holder entitled to attend and vote at the meeting of the Company is entitled to appoint one or more proxies to attend and vote on his/her behalf. ANY ALTERATION MADE TO THIS PROXY FORM MUST BE INITIALLED BY THE PERSON WHO SIGNS IT. The proxy needs not be a member of the Company, but must attend the meeting (or any adjournment thereof) to represent you.

  2. Please insert the number of shares for this proxy. If no number is inserted, this proxy form will be deemed to relate to all the shares registered in the name of the holder(s).

  3. This proxy form must be signed and dated by the shareholder or his/her attorney duly authorised in writing. If the shareholder is a company, it should execute this proxy form under its common seal or by the signature(s) of (a) person(s) authorised to sign on its behalf. In the case of joint shareholders, any one shareholder may sign this proxy form. The vote of the senior joint shareholder who tenders a vote, whether in person or by proxy, will be accepted to the exclusion of the votes of the other joint shareholder(s) and for this purpose seniority will be determined by the order in which the names stand in the register of members in respect of the joint shareholding.

  4. IMPORTANT: IF YOU WISH TO VOTE FOR THE RESOLUTION, TICK (✓) IN THE BOX BELOW MARKED ‘‘FOR’’. IF YOU WISH TO VOTE AGAINST THE RESOLUTION, TICK (✓) IN THE BOX BELOW MARKED ‘‘AGAINST’’. Failure to tick either box will entitle your proxy to cast your vote in respect of the resolution at his/her discretion or to abstain. Your proxy will also be entitled to vote at his/her discretion or to abstain on any resolution properly put to the meeting other than that referred to in the notice convening the meeting.

  5. In order to be valid, a proxy form and the power of attorney or other authority (if any) under which it is signed, or a notarially certified copy of17MsuchFloor,powerHopewellof attorney,Centre,must183be Queendeposited’s Roadat theEast,shareWanchai,registrarHongof theKong,Company,not lessComputersharethan 48 hoursHongbeforeKongtheInvestortime fixedServicesfor holdingLimited,theat meeting or any adjournment thereof.

  6. Completion and delivery of this proxy form will not preclude you from attending and voting at the meeting if you so wish.

  7. Please provide one certificate number, if possible, to facilitate processing.

  8. For the avoidance of doubt, we do not accept any special instructions written on this proxy form.